150 related articles for article (PubMed ID: 8088177)
1. Activation of bovine factor IX by the reaction product of bovine factor VII and human tissue factor.
Liu DY; Rosen S
Chin Med J (Engl); 1994 Mar; 107(3):181-5. PubMed ID: 8088177
[TBL] [Abstract][Full Text] [Related]
2. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
[TBL] [Abstract][Full Text] [Related]
3. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
[TBL] [Abstract][Full Text] [Related]
4. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ
J Androl; 2005; 26(1):146-52. PubMed ID: 15611579
[TBL] [Abstract][Full Text] [Related]
6. Activation of coagulation factor X in human semen.
Carson SD; De Jonge CJ
J Androl; 1998; 19(3):289-94. PubMed ID: 9639045
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
8. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
Almus FE; Rao LV; Rapaport SI
Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
[TBL] [Abstract][Full Text] [Related]
9. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
Livnat T; Zivelin A; Martinowitz U; Salomon O; Seligsohn U
J Thromb Haemost; 2006 Jan; 4(1):192-200. PubMed ID: 16409469
[TBL] [Abstract][Full Text] [Related]
10. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
11. Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor.
Persson E
Thromb Res; 2008; 123(1):171-6. PubMed ID: 18550154
[TBL] [Abstract][Full Text] [Related]
12. The role of factor IX in tissue thromboplastin induced coagulation.
van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
[TBL] [Abstract][Full Text] [Related]
13. Characterization of porcine factor VII, X and comparison with human factor VII, X.
Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J
Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401
[TBL] [Abstract][Full Text] [Related]
14. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.
Osterud B; Rapaport SI
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5260-4. PubMed ID: 271951
[TBL] [Abstract][Full Text] [Related]
15. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
Minami H; Nogami K; Yada K; Ogiwara K; Furukawa S; Soeda T; Kitazawa T; Shima M
J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568
[TBL] [Abstract][Full Text] [Related]
16. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
Ndonwi M; Broze G; Bajaj SP
J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
[TBL] [Abstract][Full Text] [Related]
17. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
Chen SW; Pellequer JL; Schved JF; Giansily-Blaizot M
Thromb Haemost; 2002 Jul; 88(1):74-82. PubMed ID: 12152682
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F
Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402
[TBL] [Abstract][Full Text] [Related]
19. Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts.
Cohen CT; Turner NA; Moake JL
Sci Rep; 2020 Feb; 10(1):2005. PubMed ID: 32029851
[TBL] [Abstract][Full Text] [Related]
20. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin.
Osterud B; Rapaport SI
Scand J Haematol; 1980 Mar; 24(3):213-26. PubMed ID: 7375819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
